Insights

Innovative Gene Therapy Focus Flash Therapeutics specialized in designing and bioproducing lentiviral vectors for gene, cell, RNA, and vaccine therapies, indicating a strong expertise in cutting-edge genetic medicine which could be attractive for partners seeking advanced gene therapy solutions.

Recent Leadership Appointments The appointment of Jérôme Bédier as President in mid-2023 signals a strategic leadership move that may open new business opportunities and partnerships aligned with their innovative pipeline and bioproduction capabilities.

Upcoming Clinical Production The plan to produce the first clinical batch of LentiFlash messenger RNA by the end of 2022 demonstrates immediate market readiness for RNA-based therapies, which could be relevant for biotech companies expanding into RNA therapeutics.

Funding and Investment With a recent funding round of 18 million dollars and notable private equity backing, there is significant potential for collaborations, joint ventures, or investment in advancing their bioproduction technologies and expanding their customer base.

Growth Potential Despite Liquidation Although the company is now liquidated, its technological advancements, ongoing development projects, and active partnerships present multiple opportunities for potential buyers or collaborators to integrate innovative biotech solutions into their portfolios.

Flash Therapeutics Tech Stack

Flash Therapeutics uses 8 technology products and services including LinkedIn Ads, Linkedin Insight Tag, PWA, and more. Explore Flash Therapeutics's tech stack below.

  • LinkedIn Ads
    Advertising
  • Linkedin Insight Tag
    Analytics
  • PWA
    Miscellaneous
  • reCAPTCHA
    Security
  • Google Tag Manager
    Tag Management
  • YouTube
    Video Players
  • Google Analytics
    Web Analytics
  • Apache HTTP Server
    Web Servers

Media & News

Flash Therapeutics's Email Address Formats

Flash Therapeutics uses at least 1 format(s):
Flash Therapeutics Email FormatsExamplePercentage
First.Last@flashtherapeutics.comJohn.Doe@flashtherapeutics.com
50%
First.Last@flashtherapeutics.comJohn.Doe@flashtherapeutics.com
50%

Frequently Asked Questions

Where is Flash Therapeutics's headquarters located?

Minus sign iconPlus sign icon
Flash Therapeutics's main headquarters is located at 3, Avenue Hubert Curien, Toulouse, Occitanie 31100, FR. The company has employees across 1 continents, including Europe.

What is Flash Therapeutics's official website and social media links?

Minus sign iconPlus sign icon
Flash Therapeutics's official website is flashtherapeutics.com and has social profiles on LinkedInCrunchbase.

What is Flash Therapeutics's NAICS code?

Minus sign iconPlus sign icon
Flash Therapeutics's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Flash Therapeutics have currently?

Minus sign iconPlus sign icon
As of October 2025, Flash Therapeutics has approximately 22 employees across 1 continents, including Europe. Key team members include Business & Marketing Director: A. D.Biosafety Officer & Cmc Lead: L. L.Cell Engineering Project Manager: F. S.. Explore Flash Therapeutics's employee directory with LeadIQ.

What industry does Flash Therapeutics belong to?

Minus sign iconPlus sign icon
Flash Therapeutics operates in the Pharmaceutical Manufacturing industry.

What technology does Flash Therapeutics use?

Minus sign iconPlus sign icon
Flash Therapeutics's tech stack includes LinkedIn AdsLinkedin Insight TagPWAreCAPTCHAGoogle Tag ManagerYouTubeGoogle AnalyticsApache HTTP Server.

What is Flash Therapeutics's email format?

Minus sign iconPlus sign icon
Flash Therapeutics's email format typically follows the pattern of First.Last@flashtherapeutics.com. Find more Flash Therapeutics email formats with LeadIQ.

How much funding has Flash Therapeutics raised to date?

Minus sign iconPlus sign icon
As of October 2025, Flash Therapeutics has raised $18M in funding. The last funding round occurred on Aug 07, 2021 for $18M.

When was Flash Therapeutics founded?

Minus sign iconPlus sign icon
Flash Therapeutics was founded in 2005.

Flash Therapeutics

Pharmaceutical ManufacturingFrance11-50 Employees

It is with deep regret that we announce the liquidation of FlashTherapeutics and the end of its activities.
Over the years, FlashTherapeutics has been driven by the ambition to innovate and bring transformative solutions to patients. This journey would not have been possible without the dedication of our talented team, the trust of our partners and clients, and the unwavering support from all those who believed in our mission.
We want to warmly thank all employees, collaborators, and stakeholders who contributed to this adventure. Your commitment, creativity, and passion have left a lasting mark.
Although FlashTherapeutics’ path comes to an end, we are confident that the science, partnerships, and expertise that emerged along the way will continue to live on through those who pursue innovation and progress in the service of patients.
We remain proud of our collective achievements and humbled by the privilege of having contributed, even in part, to the advancement of healthcare solutions.
To everyone who walked with us on this journey: thank you.

Section iconCompany Overview

Headquarters
3, Avenue Hubert Curien, Toulouse, Occitanie 31100, FR
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
2005
Employees
11-50

Section iconFunding & Financials

  • $18M

    Flash Therapeutics has raised a total of $18M of funding over 2 rounds. Their latest funding round was raised on Aug 07, 2021 in the amount of $18M.

  • $1M

    Flash Therapeutics's revenue is estimated to be in the range of $1M

Section iconFunding & Financials

  • $18M

    Flash Therapeutics has raised a total of $18M of funding over 2 rounds. Their latest funding round was raised on Aug 07, 2021 in the amount of $18M.

  • $1M

    Flash Therapeutics's revenue is estimated to be in the range of $1M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.